Navigation Links
Growth Trend for Gerresheimer Continues Unabated - Debt Reduction
Date:10/17/2007

DUSSELDORF, Germany, October 17 /PRNewswire/ --

- For the Nine Months (to 31 August) a 46% Sales Increase to EUR697m

- For Nine Months Almost Six-Fold Growth in EBIT to EUR34.8m (EUR6.2m)

- Marked Improvement in Adjusted EBITDA by 50% to EUR124m

- Substantial Debt Reduction and Fall in Interest Charges Since the IPO

- CEO Dr. Axel Herberg: "The Gratifying Q3 Result Confirms Our Full-Year Forecast for 2007."

In the first nine months of its financial year (to 31 August), Gerresheimer AG has continued its dynamic earnings and sales trend unabated. Total sales including the consolidated Gerresheimer Wilden Group increased by 46.3% to EUR697.4m (9M 2006: EUR476.7m). Adjusted EBITDA actually improved by 50.1% to EUR124.4 (EUR82.9m), with a margin improvement by 0.4 percentage points to 17.8% (17.4%). In the result from ordinary activities (EBIT) there was almost a six-fold increase in the comparable period to EUR34.8m (EUR6.2m). Cash net income(1) increased due to one-off expenses (EUR21.0m before tax) for the IPO by EUR16.6m to EUR0.8 (EUR-15.8m).

"The gratifying operating development has completely fulfilled our expectations," says Dr. Axel Herberg, CEO of Gerresheimer AG. "Looking at our target for the year to achieve organic growth of 8% to 9% and an EBITDA margin of close to 19%, we are right on track. We will continue to work to expand our position as a globally active pharma and life-science company."

In the third quarter (June to August) total sales grew strongly by 60.2% to EUR250.1m (third quarter of 2006: EUR156.1m). The substantial sales growth was largely attributable to the acquisition of the Wilden Group and the positive turnover trend in the pharma and cosmetics segments. In the comparable period, Adjusted EBITDA improved by 55.3% to EUR44.1m (EUR28.4m). The development in the result from ordinary activities (EBIT), which improved to EUR11.0m (EUR-1.2m), was also gratifying. The consolidated result inc
'/>"/>

SOURCE Gerresheimer AG
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. More The Usage More The Growth In The Adult Brain.
2. A new growth factor identified
3. Anthrax drug doxycycline could stunt fetal growth
4. Anti-Cancer Drug Restores Normal Cell Growth
5. Zinc may enhance growth in Young sickle cell patients
6. Drug stabilizes cancer growth
7. Enzyme stimulates growth of adult stem cells
8. Mental growth in babies at risk
9. Low-dose Growth Hormone (GH) with diet and exercise may help weight loss
10. New Molecule that can stop the growth of Viruses
11. Human Growth Hormone Found To be Dangerous For Human Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... Innovations announces the upcoming airing of Innovations with ... 20, 2014 at 7:30 a.m. EST/PT via Discovery Channel. ... scenes to learn about Break the Cycle’s comprehensive dating ... help and information Break the Cycle provides to teens ... abuse, how to navigate the legal system, and provides ...
(Date:10/1/2014)... 01, 2014 NoteSwift Inc., announced today ... 10.0, 12.1 and 13.0. NoteSwift is the bridge between ... to navigate and document clinical information at the point ... creating a patient note by more than half – ... major pain points providers state impedes EHR use according ...
(Date:10/1/2014)... Scientists at the University of Western Australia say ... proteins has the power to knock out mesothelioma in ... new study on their website. Click here to ... UWA School of Pathology and Laboratory Medicine administered anti-CD25, ... with promising results. , “A timed triple immunotherapy ...
(Date:10/1/2014)... in Bahir Dar, Ethiopia, at the occasion of ... gathered some 150 African and international leishmaniasis experts, ... safety and efficacy monitoring plan, carried out ... Sudan, Uganda, and Ethiopia, were presented to key ... to treatment of kala-azar with the combination of ...
(Date:10/1/2014)... October is national Breast Cancer Awareness ... plans while raising money for breast cancer research. Pelican ... Month in the effort to find a cure. ... importance of having access to clean, healthy water. Research ... to certain forms of cancer. , The Problem ...
Breaking Medicine News(10 mins):Health News:Innovations to Explore Breakthroughs in Health and Wellness in Upcoming Episode Airing Monday, October 20, 2014 via Discovery Channel 2Health News:NoteSwift Joins Allscripts Developer Program 2Health News:NoteSwift Joins Allscripts Developer Program 3Health News:New Mesothelioma Study Says Mice Cured by Immuntherapy “Cocktail”, Reports Surviving Mesothelioma 2Health News:Results of large-scale roll out of combination treatment for kala-azar in Eastern Africa 2Health News:Pelican Water Supports Breast Cancer Awareness Month with Order Donations 2
... Imaging (BSGI) has,been proven to be a highly ... carcinoma (ILC), a difficult to diagnose breast cancer. ... see lesions independent of,tissue density and discover very ... magnetic resonance imaging (MRI), BSGI has the,greatest sensitivity ...
... UNH ) is giving Pennsylvania children the ... childhood obesity, designing programs to,address it and implementing ... UnitedHealth HEROES is a ... working through educators and youth,leaders, to create and ...
... Money may be better spent in other areas, experts say ... teams, created to prevent cardiac arrest and deaths in critically ... finds. , "Many hospitals have implemented these teams over the ... cardiologist at the Mid America Heart Institute in Kansas City, ...
... name for the project formerly known as “Clinical Document Architecture for Common ... standards developed by the project and submitted to Health Level Seven (HL7) ... ... 2, 2008 -- "Our group has been working with many partners ...
... of Engineering has led to significant improvements in turnover ... hospitals, allowing "many more hours of daytime surgery per ... work will be expanded to include three more hospitals. ... of Industrial and Systems Engineering began work in January, ...
... Thursday December 4th Governor Howard Dean will deliver the Keynote ... the Pulse of Health IT: A Critical Review of Progress ... and Beyond." , , (Logo: ... The Keynote speech will begin at 4:30 p.m. For more ...
Cached Medicine News:Health News:Molecular Breast Imaging Has Greater Sensitivity Over Mammography, Ultrasound and MRI for Invasive Lobular Carcinoma 2Health News:UnitedHealth Group Grants to Help Students and Educators Combat Childhood Obesity 2Health News:Rapid Response Teams Don't Cut Hospital Heart Attacks, Death Rates 2Health News:Rapid Response Teams Don't Cut Hospital Heart Attacks, Death Rates 3Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 2Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 3Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 4Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 5Health News:Operations engineering for more efficient operating rooms 2Health News:Operations engineering for more efficient operating rooms 3
(Date:10/1/2014)... , Oct. 1, 2014   Plexus Information ... of Anesthesia Information Management Systems (AIMS), announced a ... , a wholly owned subsidiary of Quality Systems, ... systems and connectivity solutions.  Logo ... This partnership extends the ...
(Date:10/1/2014)... England , Oct. 1, 2014  Columbia Laboratories, ... its subsidiary, Molecular Profiles Ltd., is set to unveil ... CPhI/ICSE Worldwide event in Paris ... rapid development of both standard and complex drug products. ... incorporates the company,s existing formulation and analytical development modules, ...
(Date:10/1/2014)... NEW YORK , October 1, 2014 ... and service provider for the medical industries, announced today the expansion ... New York City . genae Americas was incorporated ... is strategically centered in one of the highest concentrations of medical ... Philippe Kassab , President at genae Americas. "The expansion of genae ...
Breaking Medicine Technology:Plexus IS' Anesthesia Documentation Solution Strengthens NextGen Healthcare Product Offering 2Plexus IS' Anesthesia Documentation Solution Strengthens NextGen Healthcare Product Offering 3Columbia Laboratories' UK Subsidiary To Launch New Development Platform At CPHI 2Columbia Laboratories' UK Subsidiary To Launch New Development Platform At CPHI 3genae Opens Offices in New York City 2
... ... Symposium, SAN ... and Systems Medicine, LLC (SM), a,wholly-owned subsidiary of CTI, announced new ... AACR-NCI-EORTC Symposium. "These studies show potential progress toward identifying specific,tumor ...
... and Effective Symptom Control, BOSTON, Oct. ... TSX: SHQ), the global specialty biopharmaceutical company, ... DAYTRANA(TM) (methylphenidate,transdermal system), the Attention Deficit Hyperactivity ... ADHD tolerability,and symptom control improvement in children ...
Cached Medicine Technology:Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 2Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 3Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 4Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 5Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system) 2Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system) 3Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system) 4Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system) 5
... of thumb motion can be difficult for ... persons with spinal cord injuries and for ... cerebral palsy or other motor or coordination ... thumb for control and coordination. Soft foam-lined ...
... weight and strong, the ThumSaver CMC Short lessens ... the CMC and/or MP joints of the thumb. ... and full IP joint motion for function. Includes ... Skiers thumb, and for rest due to repetitive ...
... common site for arthritis in the hand. The ... the wrist or other joints of the thumb. ... or reduce subluxation of the CMC joint of ... without pain. Also useful for persons experiencing pain ...
... orthosis is designed to comfortably restrict motion ... the hand in a neutral position. It ... thermoplastic whose unique characteristics offer durable performance ... rigid cast-like immobilization of the wrist, hand, ...
Medicine Products: